Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Dakir, El H."'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
BMC Proceedings; 2010 Supplement 2, Vol. 4, p1-1, 1p
Autor:
Dakir el-H; Instituto de Biología Molecular y Celular del Cáncer, Centro de Investigación del Cáncer, Consejo Superior de Investigaciones Científicas (CSIC)-Universidad de Salamanca, Salamanca, Spain.; Faculty of Biology, University of Latvia, Riga, Latvia., Mollinedo F; Instituto de Biología Molecular y Celular del Cáncer, Centro de Investigación del Cáncer, Consejo Superior de Investigaciones Científicas (CSIC)-Universidad de Salamanca, Salamanca, Spain.; Laboratory of Cell Death and Cancer Therapy, Department of Molecular Biomedicine, Centro de Investigaciones Biológicas, CSIC, Madrid, Spain.
Publikováno v:
Oncotarget [Oncotarget] 2019 Sep 03; Vol. 10 (51), pp. 5313-5331. Date of Electronic Publication: 2019 Sep 03 (Print Publication: 2019).
Autor:
Dakir el-H; Center for Cancer Research and Cell Biology, Queen's University, Belfast, UK.; Instituto de Biología Molecular y Celular del Cáncer, Centro de Investigación del Cáncer, Consejo Superior de Investigaciones Científicas (CSIC), Universidad de Salamanca, Salamanca, Spain.; Institute of Cancer Therapeutics, University of Bradford, Bradford, UK., Pickard A; Center for Cancer Research and Cell Biology, Queen's University, Belfast, UK., Srivastava K; Center for Cancer Research and Cell Biology, Queen's University, Belfast, UK., McCrudden CM; School of Pharmacy, Queen's University Belfast, Belfast, UK., Gross SR; School of Life and Health Sciences, Aston University, Birmingham, UK., Lloyd S; School of Medicine, Animal Facility, Queen's University Belfast, Belfast, UK., Zhang SD; Northern Ireland Centre for Stratified Medicine, Biomedical Sciences, University of Ulster, UK., Margariti A; Center of Experimental Medicine, Queen's University Belfast, Belfast, UK., Morgan R; Institute of Cancer Therapeutics, University of Bradford, Bradford, UK., Rudland PS; Institute of integrative Biology, University of Liverpool, Liverpool, UK., El-Tanani M; Institute of Cancer Therapeutics, University of Bradford, Bradford, UK.
Publikováno v:
Oncotarget [Oncotarget] 2018 Oct 09; Vol. 9 (79), pp. 34889-34910. Date of Electronic Publication: 2018 Oct 09 (Print Publication: 2018).
Autor:
El-Tanani M; Institute of Cancer Therapeutics, University of Bradford, Bradford, West Yorkshire BD7 1DP, UK. m.el-tanani@bradford.ac.uk., Dakir el-H; Institute of Cancer Therapeutics, University of Bradford, Bradford, West Yorkshire BD7 1DP, UK. E.H.Dakir@bradford.ac.uk., Raynor B; Institute of Cancer Therapeutics, University of Bradford, Bradford, West Yorkshire BD7 1DP, UK. bethrayy@hotmail.com., Morgan R; Institute of Cancer Therapeutics, University of Bradford, Bradford, West Yorkshire BD7 1DP, UK. R.Morgan3@bradford.ac.uk.
Publikováno v:
Cancers [Cancers (Basel)] 2016 Mar 14; Vol. 8 (3). Date of Electronic Publication: 2016 Mar 14.
Autor:
Chan KK; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast BT9 7BL, United Kingdom; Department of Pathology, The University of Hong Kong , Hong Kong Special Administrative Region., Matchett KB; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast BT9 7BL, United Kingdom., McEnhill PM; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast BT9 7BL, United Kingdom., Dakir el H; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast BT9 7BL, United Kingdom., McMullin MF; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast BT9 7BL, United Kingdom., El-Tanani Y; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast BT9 7BL, United Kingdom., Patterson L; Institute of Cancer Therapeutics, University of Bradford, Bradford, West Yorkshire BD7 1DP, United Kingdom., Faheem A; School of Pharmacy and Pharmaceutical Sciences, Ulster University, Cromore Road, Coleraine BT52 1SA, United Kingdom., Rudland PS; Institute of Integrative Biology, University of Liverpool, Crown Street, Liverpool L69 7ZB, United Kingdom., McCarron PA; School of Pharmacy and Pharmaceutical Sciences, Ulster University, Cromore Road, Coleraine BT52 1SA, United Kingdom., El-Tanani M; Institute of Cancer Therapeutics, University of Bradford, Bradford, West Yorkshire BD7 1DP, United Kingdom. Electronic address: M.El-Tanani@bradford.ac.uk.
Publikováno v:
Cytokine & growth factor reviews [Cytokine Growth Factor Rev] 2015 Aug; Vol. 26 (4), pp. 415-23. Date of Electronic Publication: 2015 May 31.
Autor:
Bonilla X; Instituto de Biología Molecular y Celular del Cáncer, Centro de Investigación del Cáncer, Consejo Superior de Investigaciones Científicas (CSIC)-Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain., Dakir el-H; Instituto de Biología Molecular y Celular del Cáncer, Centro de Investigación del Cáncer, Consejo Superior de Investigaciones Científicas (CSIC)-Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain.; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK., Mollinedo F; Instituto de Biología Molecular y Celular del Cáncer, Centro de Investigación del Cáncer, Consejo Superior de Investigaciones Científicas (CSIC)-Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Hospital Universitario de Salamanca, Salamanca, Spain., Gajate C; Instituto de Biología Molecular y Celular del Cáncer, Centro de Investigación del Cáncer, Consejo Superior de Investigaciones Científicas (CSIC)-Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Hospital Universitario de Salamanca, Salamanca, Spain.
Publikováno v:
Oncotarget [Oncotarget] 2015 Jun 10; Vol. 6 (16), pp. 14596-613.